Market Cap 294.89M
Revenue (ttm) 0.00
Net Income (ttm) -59.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 144,000
Avg Vol 213,116
Day's Range N/A - N/A
Shares Out 126.56M
Stochastic %K 20%
Beta 1.45
Analysts Strong Sell
Price Target $4.00

Company Profile

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 333 2001
Address:
2701 Eastlake Avenue East, Seattle, United States
Omega_Proxy
Omega_Proxy Mar. 10 at 8:02 PM
$NAUT Mark my humble, informed opinion. This company can go >100x from current valuation. DYOR
1 · Reply
tievLeaf
tievLeaf Mar. 10 at 3:14 PM
$QSI holy fuuck, knew it wouldn't stay under 1 for too long. $SLS $RGTI $NAUT $NVDA
0 · Reply
buysellrepeatreboot
buysellrepeatreboot Mar. 6 at 5:59 AM
$NAUT trash?
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 5 at 1:40 AM
$NAUT CEO purchased 25,000 shares at $2.61 for a total of $65,238. Patel Sujal M now owns 17,461,232 shares. https://ceo-buys.com
0 · Reply
islandpunk
islandpunk Mar. 5 at 12:47 AM
$NAUT NAUT two large insider purchases just filed. Sujal Patel: Co-founder and CEO of Nautilus. - 16% Parag Mallick, Ph.D.: Co-founder and Chief Scientist. - 17% https://www.sec.gov/Archives/edgar/data/1808805/000185794826000003/xslSCHEDULE_13D_X01/primary_doc.xml https://www.sec.gov/Archives/edgar/data/1378830/000137883026000005/xslSCHEDULE_13D_X01/primary_doc.xml
0 · Reply
Bbboston
Bbboston Mar. 4 at 1:23 AM
$NAUT Why is it green today? Somebody bought in or somebody is playin.
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 8:19 PM
$NAUT Current Stock Price: $2.41 Contracts to trade: $2.5 NAUT Mar 20 2026 Call Entry: $0.05 Exit: $0.07 ROI: 33% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
erevnon
erevnon Feb. 27 at 5:01 PM
Guggenheim maintains Nautilus Biotechnology $NAUT at Buy and raises the price target from $2.5 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Bbboston
Bbboston Feb. 27 at 1:31 PM
$NAUT You are correct. The price action is irrelevant at this point. No rev to speak of and even the tech itself has not yet proved itself. But Proteomics is the future and founders are heavily invested in this with their own money so they are not playing around. I made a mistake of entering too early. I first but this before Amazon did 😞, but I am in the green now and waiting to buy more when market correction happens. This is still a couple of years away.
1 · Reply
birdupyoubird
birdupyoubird Feb. 26 at 7:05 PM
$NAUT nice opportunity for entry today. The investment thesis did not change at all with this earnings report.
0 · Reply
Latest News on NAUT
Nautilus: Trading Below An Albeit Lower Net Cash Figure

Feb 28, 2025, 6:59 PM EST - 1 year ago

Nautilus: Trading Below An Albeit Lower Net Cash Figure


Nautilus Biotechnology Expands to San Diego

Jan 26, 2023, 7:45 AM EST - 3 years ago

Nautilus Biotechnology Expands to San Diego


Omega_Proxy
Omega_Proxy Mar. 10 at 8:02 PM
$NAUT Mark my humble, informed opinion. This company can go >100x from current valuation. DYOR
1 · Reply
tievLeaf
tievLeaf Mar. 10 at 3:14 PM
$QSI holy fuuck, knew it wouldn't stay under 1 for too long. $SLS $RGTI $NAUT $NVDA
0 · Reply
buysellrepeatreboot
buysellrepeatreboot Mar. 6 at 5:59 AM
$NAUT trash?
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 5 at 1:40 AM
$NAUT CEO purchased 25,000 shares at $2.61 for a total of $65,238. Patel Sujal M now owns 17,461,232 shares. https://ceo-buys.com
0 · Reply
islandpunk
islandpunk Mar. 5 at 12:47 AM
$NAUT NAUT two large insider purchases just filed. Sujal Patel: Co-founder and CEO of Nautilus. - 16% Parag Mallick, Ph.D.: Co-founder and Chief Scientist. - 17% https://www.sec.gov/Archives/edgar/data/1808805/000185794826000003/xslSCHEDULE_13D_X01/primary_doc.xml https://www.sec.gov/Archives/edgar/data/1378830/000137883026000005/xslSCHEDULE_13D_X01/primary_doc.xml
0 · Reply
Bbboston
Bbboston Mar. 4 at 1:23 AM
$NAUT Why is it green today? Somebody bought in or somebody is playin.
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 8:19 PM
$NAUT Current Stock Price: $2.41 Contracts to trade: $2.5 NAUT Mar 20 2026 Call Entry: $0.05 Exit: $0.07 ROI: 33% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
erevnon
erevnon Feb. 27 at 5:01 PM
Guggenheim maintains Nautilus Biotechnology $NAUT at Buy and raises the price target from $2.5 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Bbboston
Bbboston Feb. 27 at 1:31 PM
$NAUT You are correct. The price action is irrelevant at this point. No rev to speak of and even the tech itself has not yet proved itself. But Proteomics is the future and founders are heavily invested in this with their own money so they are not playing around. I made a mistake of entering too early. I first but this before Amazon did 😞, but I am in the green now and waiting to buy more when market correction happens. This is still a couple of years away.
1 · Reply
birdupyoubird
birdupyoubird Feb. 26 at 7:05 PM
$NAUT nice opportunity for entry today. The investment thesis did not change at all with this earnings report.
0 · Reply
Impacto
Impacto Feb. 26 at 6:06 PM
$NAUT I am IN
1 · Reply
Rebooter
Rebooter Feb. 26 at 4:07 PM
$NAUT $365 million market cap for a company with "no material revenue" and increasing operating expenses. What could possibly go wrong.
0 · Reply
Omega_Proxy
Omega_Proxy Feb. 26 at 4:02 PM
$NAUT Not enough upward momentum now. Wait for the next catalyst.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 1:27 PM
$NAUT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.11 up 21.43% YoY • Nautilus Biotechnology expects 2026 operating expenses to increase by 15-20% year over year, with no material revenue anticipated from Early Access Program engagements. Nautilus Biotechnology has sufficient resources to fund operations through 2027.
0 · Reply
WOLFSTREET
WOLFSTREET Feb. 25 at 10:13 PM
$NAUT @WorkingGal CC can do this all day. Smooth 50% gains in 1 month, and looks like this is just in chill mode. I do hope I post enough ideas on here, ya just need a few to hit homeruns. I cannot buy them all, I cannot share them all, but I do try... OK, now that we are past all that, back to posting historical data to see how well CC calls each and every stock, currently 3900+ in the database. CHEERS!
0 · Reply
bilocelhi
bilocelhi Feb. 25 at 3:45 PM
$NAUT $5 shortly
1 · Reply
birdupyoubird
birdupyoubird Feb. 25 at 8:34 AM
$NAUT Voyager Platform has been announced https://www.nautilus.bio/voyager-platform/
0 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 12:42 PM
$PHOE $NAUT $WTF $TALK •••
0 · Reply
bilocelhi
bilocelhi Feb. 20 at 1:40 PM
$NAUT still only 2K watchers, flying very well under the radar. Gonna be 🔥 , shortly
0 · Reply
bilocelhi
bilocelhi Feb. 20 at 3:21 AM
$CAPR take a look at $NAUT going to make eye-popping moves. Current gradual set-up is 🔥
1 · Reply
bilocelhi
bilocelhi Feb. 20 at 12:51 AM
$NAUT 💯
0 · Reply
bilocelhi
bilocelhi Feb. 19 at 10:45 PM
$NAUT 33% since nice, headed to $5 give or take a week
0 · Reply